ReviewBioMed research international2014
Multiparametric MRI in the PSA screening era.
Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Reproducibility of Multiparametric Magnetic Resonance Imaging and Fusion Guided Prostate Biopsy: Multi-Institutional External Validation by a Propensity Score Matched Cohort.The Journal of urology · 2016Trial
- Tracked Foley catheter for motion compensation during fusion image-guided prostate procedures: a phantom study.European radiology experimental · 2020Article
- The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis.Scientific reports · 2018Article
- Interreader Agreement of Prostate Imaging Reporting and Data System Version 2 Using an In-Bore MRI-Guided Prostate Biopsy Cohort: A Single Institution's Initial Experience.AJR. American journal of roentgenology · 2017Article
- Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation.Translational andrology and urology · 2017Review
- Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.The Journal of urology · 2017Article
- Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.Urologic oncology · 2017Article
- Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Future oncology (London, England) · 2016Review
- Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.International urology and nephrology · 2016Article
- Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling.The Journal of urology · 2016Article
- A urologist's perspective on prostate cancer imaging: past, present, and future.Abdominal radiology (New York) · 2016Article
- Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.Current urology reports · 2016Review
- Article
- Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.Journal of endourology · 2015Article
- Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy.Abdominal imaging · 2015Article
- Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.Current urology reports · 2015Review
- The role of MRI in active surveillance for prostate cancer.Current urology reports · 2015Review
- Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.Urologic oncology · 2015Article
- Targeted prostate biopsy using magnetic resonance imaging-ultrasound fusion.Asian journal of andrologyArticle
- An Evidenced Based Review and Common-Sense Approach to Prostate Cancer Screening for Primary Care Physicians, in an Era of Conflicting Guideline Recommendations and Debate.Journal of primary care & community healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Prostate cancer remains significant public health concern amid growing controversies regarding prostate specific antigen (PSA) based screening. The utility of PSA has been brought into question, and alternative measures are investigated to remedy the overdetection of indolent disease and safeguard patients from the potential harms resulting from an elevated PSA. Multiparametric MRI of the prostate has shown promise in identifying patients at risk for clinically significant disease but its role within the current diagnostic and treatment paradigm remains in question. The current review focuses on recent applications of MRI in this pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.